Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 191

The DOI matches its Crossref record.

Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study

Italiano, Antoine, Di Mauro, Ilaria, Rapp, Jocelyn, Pierron, Gaëlle, Auger, Nathalie, Alberti, Laurent, Chibon, Frédéric, Escande, Fabienne, Voegeli, Anne-Claire, Ghnassia, Jean-Pierre, Keslair, Frédérique, Laé, Marick, Ranchère-Vince, Dominique, Terrier, Philippe, Baffert, Sandrine, Coindre, Jean-Michel, Pedeutour, Florence·2016·The Lancet Oncology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1470-2045(15)00583-5

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 27

  1. Arbiser, 2001, Consultative (expert) second opinions in soft tissue pathology. Analysis of problem-prone diagnostic situations, Am J Clin Pathol, 116, 473, 10.1309/425H-NW4W-XC9A-005H · DOI
  2. Ray-Coquard, 2012, Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions, Ann Oncol, 23, 2442, 10.1093/annonc/mdr610 · DOI · Paper page
  3. Thway, 2009, Histopathological diagnostic discrepancies in soft tissue tumours referred to a specialist centre, Sarcoma, 2009, 741975, 10.1155/2009/741975 · DOI
  4. Delattre, 1994, The Ewing family of tumors—a subgroup of small-round-cell tumors defined by specific chimeric transcripts, N Engl J Med, 331, 294, 10.1056/NEJM199408043310503 · DOI · Paper page
  5. Coindre, 2003, Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 cases, Cancer, 98, 2700, 10.1002/cncr.11840 · doi:10.1002/cncr.11840
  6. Guillou, 2001, Hum Pathol, 32, 105, 10.1053/hupa.2001.21130 · doi:10.1053/hupa.2001.21130
  7. Hostein, 2004, Rhabdomyosarcoma: value of myogenin expression analysis and molecular testing in diagnosing the alveolar subtype: an analysis of 109 paraffin-embedded specimens, Cancer, 101, 2817, 10.1002/cncr.20711 · DOI
  8. Williamson, 2010, Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma, J Clin Oncol, 28, 2151, 10.1200/JCO.2009.26.3814 · DOI · Paper page
  9. Coindre, 2006, Diagnosis of clear cell sarcoma by real-time reverse transcriptase-polymerase chain reaction analysis of paraffin embedded tissues: clinicopathologic and molecular analysis of 44 patients from the French sarcoma group, Cancer, 107, 1055, 10.1002/cncr.22099 · doi:10.1002/cncr.22099
  10. de Vreeze, 2010, Added value of molecular biological analysis in diagnosis and clinical management of liposarcoma: a 30-year single-institution experience, Ann Surg Oncol, 17, 686, 10.1245/s10434-009-0806-9 · doi:10.1245/s10434-009-0806-9
  11. Sirvent, 2007, Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR, Am J Surg Pathol, 31, 1476, 10.1097/PAS.0b013e3180581fff · DOI · Paper page
  12. Weaver, 2008, Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms, Mod Pathol, 21, 943, 10.1038/modpathol.2008.84 · DOI · Paper page
  13. Neuville, 2013, Impact of molecular analysis on the final sarcoma diagnosis: a study on 763 cases collected during a European epidemiological study, Am J Surg Pathol, 37, 1259, 10.1097/PAS.0b013e31828f51b9 · DOI
  14. Karanian, 2015, Fluorescence in situ hybridization analysis is a helpful test for the diagnosis of dermatofibrosarcoma protuberans, Mod Pathol, 28, 230, 10.1038/modpathol.2014.97 · doi:10.1038/modpathol.2014.97
  15. 2014, Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, 25, iii102
  16. Blay, 2015, Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial, Lancet Oncol, 16, 531, 10.1016/S1470-2045(15)70102-6 · doi:10.1016/s1470-2045(15)70102-6
  17. von Mehren, 2014, Soft tissue sarcoma, version 2. 2014, J Natl Compr Canc Netw, 12, 473, 10.6004/jnccn.2014.0053 · DOI
  18. Kroep, 2011, First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group study, Ann Oncol, 22, 207, 10.1093/annonc/mdq338 · doi:10.1093/annonc/mdq338
  19. Coindre, 2004, Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity, J Pathol, 203, 822, 10.1002/path.1579 · DOI
  20. Le Guellec, 2014, Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?, Am J Surg Pathol, 38, 293, 10.1097/PAS.0000000000000131 · doi:10.1097/pas.0000000000000131
  21. Italiano, 2008, HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon, Int J Cancer, 122, 2233, 10.1002/ijc.23380 · DOI · Paper page
  22. Ficher, 2014, The diversity of soft tissue tumours with EWSR1 gene rearrangements: a review, Histopathology, 64, 134, 10.1111/his.12269 · DOI · Paper page
  23. Antonescu, 2014, Promiscuous genes involved in recurrent chromosomal translocations in soft tissue tumours, Pathology, 46, 105, 10.1097/PAT.0000000000000049 · DOI
  24. Argani, 2001, Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents, Am J Pathol, 159, 179, 10.1016/S0002-9440(10)61684-7 · DOI · Paper page
  25. Laé, 2009, Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum, Mod Pathol, 22, 291, 10.1038/modpathol.2008.184 · doi:10.1038/modpathol.2008.184
  26. Patel, 2015, Molecular inimitability amongst tumors: implications for precision cancer medicine in the age of personalized oncology, Oncotarget, 6, 32602, 10.18632/oncotarget.5289 · DOI
  27. Italiano, 2007, Gains and complex rearrangements of the 12q13-15 chromosomal region in ordinary lipomas: the “missing link” between lipomas and liposarcomas?, Int J Cancer, 121, 308, 10.1002/ijc.22685 · doi:10.1002/ijc.22685

Cited by

See all 191

Metadata

Authors
Italiano, A., Di Mauro, I., Rapp, J., Pierron, G., Auger, N., Alberti, L., Chibon, F., Escande, F., Voegeli, A.-C., Ghnassia, J.-P., Keslair, F., Laé, M., Ranchère-Vince, D., Terrier, P., Baffert, S., Coindre, J.-M., & Pedeutour, F.
Venue
The Lancet Oncology
Publisher
Elsevier BV
Published
2016-04
Volume
17
Issue
4
Pages
532-538
ISSN
1470-2045 (ISSN-L)
OpenAlex
W2295993263
Cited by
191
References
0
FWCI
12.45
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • Institut National Du Cancer
  • Centre Hospitalier Universitaire de Nice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study. https://app.cochat.ai/papers/10.1016/s1470-2045(15)00583-5
The paper
Italiano, A., Di Mauro, I., Rapp, J., Pierron, G., Auger, N., Alberti, L., Chibon, F., Escande, F., Voegeli, A.-C., Ghnassia, J.-P., Keslair, F., Laé, M., Ranchère-Vince, D., Terrier, P., Baffert, S., Coindre, J.-M., & Pedeutour, F. (2016). Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(15)00583-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.